Abivax (ABVX) Competitors $7.76 +0.10 (+1.31%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$7.94 +0.18 (+2.31%) As of 07:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABVX vs. EWTX, SDGR, BHVN, ETNB, ANIP, JANX, EVO, MESO, VERA, and OCULShould you be buying Abivax stock or one of its competitors? The main competitors of Abivax include Edgewise Therapeutics (EWTX), Schrodinger (SDGR), Biohaven (BHVN), 89BIO (ETNB), ANI Pharmaceuticals (ANIP), Janux Therapeutics (JANX), Evotec (EVO), Mesoblast (MESO), Vera Therapeutics (VERA), and Ocular Therapeutix (OCUL). These companies are all part of the "pharmaceutical products" industry. Abivax vs. Its Competitors Edgewise Therapeutics Schrodinger Biohaven 89BIO ANI Pharmaceuticals Janux Therapeutics Evotec Mesoblast Vera Therapeutics Ocular Therapeutix Abivax (NASDAQ:ABVX) and Edgewise Therapeutics (NASDAQ:EWTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation. Does the media refer more to ABVX or EWTX? In the previous week, Edgewise Therapeutics had 19 more articles in the media than Abivax. MarketBeat recorded 19 mentions for Edgewise Therapeutics and 0 mentions for Abivax. Abivax's average media sentiment score of 1.87 beat Edgewise Therapeutics' score of 0.52 indicating that Abivax is being referred to more favorably in the media. Company Overall Sentiment Abivax Very Positive Edgewise Therapeutics Positive Is ABVX or EWTX more profitable? Abivax's return on equity of 0.00% beat Edgewise Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets AbivaxN/A N/A N/A Edgewise Therapeutics N/A -30.95%-29.45% Do analysts rate ABVX or EWTX? Abivax currently has a consensus price target of $31.00, indicating a potential upside of 299.48%. Edgewise Therapeutics has a consensus price target of $40.00, indicating a potential upside of 207.46%. Given Abivax's stronger consensus rating and higher possible upside, equities analysts clearly believe Abivax is more favorable than Edgewise Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abivax 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00Edgewise Therapeutics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.80 Do insiders and institutionals have more ownership in ABVX or EWTX? 47.9% of Abivax shares are owned by institutional investors. 23.2% of Edgewise Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable valuation & earnings, ABVX or EWTX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbivaxN/AN/A-$190.71MN/AN/AEdgewise TherapeuticsN/AN/A-$133.81M-$1.55-8.39 Which has more volatility & risk, ABVX or EWTX? Abivax has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, Edgewise Therapeutics has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. SummaryAbivax beats Edgewise Therapeutics on 8 of the 12 factors compared between the two stocks. Get Abivax News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABVX vs. The Competition Export to ExcelMetricAbivaxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$486.06M$2.88B$5.54B$8.87BDividend YieldN/A2.64%5.39%4.10%P/E RatioN/A21.3126.2319.90Price / SalesN/A278.47413.23113.66Price / CashN/A41.4736.1356.90Price / Book11.257.518.045.38Net Income-$190.71M-$55.05M$3.15B$248.50M7 Day Performance8.08%2.07%1.44%2.04%1 Month Performance0.26%4.84%3.62%4.84%1 Year Performance-40.63%5.37%34.68%20.23% Abivax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABVXAbivax2.4742 of 5 stars$7.76+1.3%$31.00+299.5%-42.5%$486.06MN/A0.0061Positive NewsEWTXEdgewise Therapeutics2.6574 of 5 stars$14.18-0.8%$39.78+180.5%-29.2%$1.50BN/A-9.1560News CoverageAnalyst ForecastAnalyst RevisionSDGRSchrodinger2.6597 of 5 stars$20.35-0.5%$32.80+61.2%+3.1%$1.50B$207.54M-7.74790BHVNBiohaven2.7983 of 5 stars$14.44-0.2%$58.46+305.0%-56.8%$1.48BN/A-1.54239ETNB89BIO1.9522 of 5 stars$10.00-0.8%$26.43+164.3%+32.9%$1.47BN/A-2.9640ANIPANI Pharmaceuticals3.7301 of 5 stars$66.03+0.7%$80.13+21.3%+4.1%$1.42B$614.38M-51.99600JANXJanux Therapeutics1.8411 of 5 stars$22.88-3.1%$95.25+316.3%-38.8%$1.40B$10.59M-16.8230EVOEvotec1.6588 of 5 stars$3.81+1.3%$5.93+55.7%-12.3%$1.34B$862.40M0.004,827Positive NewsMESOMesoblast2.1402 of 5 stars$10.16-2.7%$18.00+77.2%+68.4%$1.33B$5.90M0.0080Gap DownVERAVera Therapeutics3.6004 of 5 stars$21.65+3.8%$65.00+200.2%-32.3%$1.33BN/A-7.2240Positive NewsOCULOcular Therapeutix3.7975 of 5 stars$8.37+3.0%$17.33+107.1%+41.6%$1.30B$63.72M-7.28230 Related Companies and Tools Related Companies EWTX Competitors SDGR Competitors BHVN Competitors ETNB Competitors ANIP Competitors JANX Competitors EVO Competitors MESO Competitors VERA Competitors OCUL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABVX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredMake 22x more from this summer’s Bitcoin boomBitcoin is on fire again. Wall Street’s piling in. ETFs are smashing volume records. And regular investors ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abivax SA Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Abivax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABVX Stock Alerts